JP2007322293A - De novo sequence analysis method, analysis software, storage medium storing analysis software, and reagent kit - Google Patents

De novo sequence analysis method, analysis software, storage medium storing analysis software, and reagent kit Download PDF

Info

Publication number
JP2007322293A
JP2007322293A JP2006154148A JP2006154148A JP2007322293A JP 2007322293 A JP2007322293 A JP 2007322293A JP 2006154148 A JP2006154148 A JP 2006154148A JP 2006154148 A JP2006154148 A JP 2006154148A JP 2007322293 A JP2007322293 A JP 2007322293A
Authority
JP
Japan
Prior art keywords
sequence analysis
novo
novo sequence
analysis method
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006154148A
Other languages
Japanese (ja)
Other versions
JP4832168B2 (en
Inventor
Masayoshi Koda
公良 甲田
Kohei Mochizuki
康平 望月
Eri Yamashita
絵理 山下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi High Tech Corp
Original Assignee
Hitachi High Technologies Corp
Hitachi High Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi High Technologies Corp, Hitachi High Tech Corp filed Critical Hitachi High Technologies Corp
Priority to JP2006154148A priority Critical patent/JP4832168B2/en
Publication of JP2007322293A publication Critical patent/JP2007322293A/en
Application granted granted Critical
Publication of JP4832168B2 publication Critical patent/JP4832168B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To solve the problems wherein, when performing de novo sequence analysis from a mass spectrum acquired by a liquid chromatograph mass spectrometer equipped with collision induction dissociation, accurate amino acid sequence is difficult, since distinction between each value of b-series including N-terminal and y-series including C-terminal is impossible. <P>SOLUTION: When performing enzyme digestion, a functional group having a large mass number is introduced into the C-terminal side by using a lysyl end peptidase (Lys-C) enzyme or the like having a high condensing efficiency. When measuring by the mass spectrometer after introduction, the y-series (into which the functional group is not introduced) can be discriminated simply from the b-series into which the functional group is introduced from the mass number by the mass spectrometer. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は生化学分野におけるプロテオミックスの中でデータベースが存在しないたんぱく質,ペプチドについてアミノ酸配列解析を行うデノボシーケンスにおいて正確にアミノ酸配列解析できるツールに関するものである。   The present invention relates to a tool capable of accurate amino acid sequence analysis in a de novo sequence for performing amino acid sequence analysis on proteins and peptides that do not have a database among proteomics in the biochemical field.

タンパク質の同定やアミノ酸配列解析は、目的のタンパク質を酵素消化して数から数十アミノ酸残基のペプチドフラグメントにしてから、衝突誘起解裂を備えた液体クロマトグラフ質量分析装置により、得られたペプチドフラグメントのマススペクトルの質量数情報と遺伝子情報をもとに作成させたデータベースから合致している数学的値を基に行われてきた。遺伝子的によく研究されているヒトやマウスなどの生物種は、データベースが充実しているが、他の大部分の生物種はデータ登録数が少なくデータベースとして機能していない。もしくはまったくデータベースとして存在していない。データベースが存在しないと衝突誘起解裂を備えた液体クロマトグラフ質量分析装置において得られたマススペクトルだけでは、ペプチドを衝突誘起解裂した後、N末端を有するb系列とC末端を有するy系列の判別が困難になり正確にアミノ酸配列解析は行えない。   For protein identification and amino acid sequence analysis, the target protein is enzymatically digested into peptide fragments of several to several tens of amino acid residues, and then the peptide obtained by a liquid chromatograph mass spectrometer equipped with collision-induced cleavage is used. This has been done on the basis of mathematical values that match from the database created based on the mass number information and gene information of the mass spectrum of the fragment. Biological species such as humans and mice, which are well studied genetically, have a well-developed database, but most other species have few data registrations and do not function as databases. Or it does not exist as a database at all. In the absence of a database, the mass spectrum obtained in a liquid chromatograph mass spectrometer equipped with collision-induced cleavage alone can be used for the b-series having an N-terminus and the y-series having a C-terminus after collision-induced cleavage of the peptide. Discrimination becomes difficult and the amino acid sequence cannot be analyzed accurately.

蛋白質核酸酵素 Vol29 No.1(1984)p49−56Protein Nucleic Acid Enzyme Vol29 No.1 (1984) p49-56

一般的にデノボシーケンス解析は、衝突誘起解裂を備えた液体クロマトグラフ質量分析計より得られたマススペクトルの質量数情報を基にN末端を含むb系列とC末端を含むy系列の値を区別することなくアミノ酸配列を当てはめていく。このためアミノ酸配列の可能性が多くなり、正確なアミノ酸配列を決定できない。本発明では、タンパク質を酵素消化するさいに縮合反応を優先する酵素選択と反応条件を設定することにより、C末端側に選択的に別の官能基を導入することにより、普通の酵素消化した脱水反応と比較して質量数的に明らかに違いが分かるようになる。この反応を用いることでy系列とb系列を明確に識別することを可能にし、プログラムされたソフトウェアを使って簡単にデノボシーケンスを行うための手法である。   In general, de novo sequence analysis is based on the mass number information of the mass spectrum obtained from a liquid chromatograph mass spectrometer equipped with collision-induced cleavage, and the values of the b series including the N terminus and the y series including the C terminus. The amino acid sequence is applied without distinction. For this reason, the possibility of an amino acid sequence increases, and an accurate amino acid sequence cannot be determined. In the present invention, when enzymatic digestion of a protein is performed, an enzyme selection and a reaction condition that give priority to the condensation reaction are set, and by introducing another functional group selectively on the C-terminal side, dehydration obtained by ordinary enzyme digestion is performed. Compared with the reaction, the difference in mass number becomes clear. By using this reaction, it is possible to clearly distinguish the y series and the b series, and this is a technique for easily performing a de novo sequence using programmed software.

測定すべきタンパク質を酵素消化するさいに、すでに知られている縮合効率の高いリジルエンドペプチダーゼ(Lys−C)酵素を選択し、反応条件は、有機溶媒(ジメチルホルムアミド)高存在下で、酵素反応の至適pHを縮合反応に有利となるようにすこし酸性側にシフトし、基質の10倍以上の導入物質を添加することで、酵素消化するとき縮合反応をさせる。これによりC末端側に質量数の大きな官能基を導入する。導入後、質量分析計で測定するとy系列(官能基の導入されていない)と官能基が導入されているb系列を質量分析計の質量数から簡単に判別できる。   For enzymatic digestion of the protein to be measured, a known lysyl endopeptidase (Lys-C) enzyme with high condensation efficiency is selected, and the reaction conditions are an enzyme reaction in the presence of a high organic solvent (dimethylformamide). The optimum pH is slightly shifted to the acidic side so as to be advantageous for the condensation reaction, and the introduction reaction is carried out by 10 times or more of the substrate so that the condensation reaction is carried out during the enzymatic digestion. This introduces a functional group having a large mass number on the C-terminal side. After introduction, when measured with a mass spectrometer, the y series (with no functional group introduced) and the b series with a functional group introduced can be easily distinguished from the mass number of the mass spectrometer.

本発明により、データベースに依存しないデノボシーケンス解析が正確にかつ短時間に行えるようになる。   According to the present invention, de novo sequence analysis independent of a database can be performed accurately and in a short time.

本発明の一実施例を図面を用いて説明する。   An embodiment of the present invention will be described with reference to the drawings.

図1はデノボシーケンス解析反応手順と縮合反応試薬キットの構成図である。タンパク質の入ったチューブ5に試薬キットの有機溶媒(ジメチルホルムアミド)1を25〜75%の範囲で加える、次に試薬キットトリス緩衝液2を75〜25%の範囲で加える。次に試薬キット導入物質(フェニルヒドラジン)3をタンパク質量の約10〜100倍加える。よく攪拌した後試薬キット酵素(Lys−C)4を2〜20μg加え37℃に保ち酵素反応を4時間から16時間行う。この反応キットおよび反応条件により図2のように
3+(OH)の代わりに導入基フェニルヒドラジンがペプチド結合(N−C)切断後C末端側に導入される。酵素消化されたペプチドフラグメントは、衝突誘起解裂を備えた液体クロマトグラフ質量分析計でアミノ酸配列解析を行う。図3は、アミノ酸8残基で構成されたペプチドフラグメントのマススペクトルの例を示す。質量分析の衝突誘起気解裂でペプチドフラグメントを解析すると無作為にペプチド結合が切れてマススペクトルのパターンからはN末端を有するb系列とC末端を有するy系列を明確に判別することは困難であるが、導入基フェニルヒドラジンを導入した反応では、C末端側でフェニルヒドラジンの質量数106だけシフトしたマススペクトルが確認される。図4は、質量分析計によって同じ測定試料から酵素消化法を変えて得られた質量数リストである。図5は、図4の2つの質量数リストからデノボシーケンス解析する方法のフローチャートである。図4の酵素消化の質量数リストの最初の値からデノボ酵素消化の質量数リストの値と比較して元の値より質量数で導入基の106シフトしている値を探し出す。それを最後の値まで行い抽出された値がy系列の候補となる。同様に2つのリストから同一の質量数を抽出することでb系列の候補を探しだす。また上記の条件に合わない値は、溶媒やインターナルフラグメントに由来しているイオンとして分類できる。図6はb系列の候補として抽出されたリストとb系列の候補として抽出されたリストである。大きな値から近接した小さな値を引くことでその差がアミノ酸に対応している。この結果からSFL(I)DSGYRのアミノ酸配列解析が可能となる。
FIG. 1 is a configuration diagram of a de novo sequence analysis reaction procedure and a condensation reaction reagent kit. The reagent kit organic solvent (dimethylformamide) 1 is added in the range of 25-75% to the tube 5 containing the protein, and then the reagent kit Tris buffer 2 is added in the range of 75-25%. Next, the reagent kit introduction substance (phenylhydrazine) 3 is added about 10 to 100 times the amount of protein. After stirring well, 2 to 20 μg of reagent kit enzyme (Lys-C) 4 is added and maintained at 37 ° C., and the enzyme reaction is performed for 4 to 16 hours. According to this reaction kit and reaction conditions, as shown in FIG. 2, the introduction group phenylhydrazine is introduced into the C-terminal side after cleaving the peptide bond (NC) instead of H 3 O + (OH). The enzymatically digested peptide fragment is subjected to amino acid sequence analysis with a liquid chromatograph mass spectrometer equipped with collision-induced cleavage. FIG. 3 shows an example of a mass spectrum of a peptide fragment composed of 8 amino acid residues. When peptide fragments are analyzed by mass-induced collision-induced gas fragmentation, peptide bonds are randomly broken and it is difficult to clearly discriminate between b-series having an N-terminus and y-series having a C-terminus from the mass spectrum pattern. However, in the reaction in which the introduction group phenylhydrazine is introduced, a mass spectrum shifted by the mass number 106 of phenylhydrazine on the C-terminal side is confirmed. FIG. 4 is a mass number list obtained by changing the enzyme digestion method from the same measurement sample by a mass spectrometer. FIG. 5 is a flowchart of a method for de novo sequence analysis from the two mass number lists of FIG. Compared with the value of the mass number list of the de novo enzyme digestion from the first value of the mass number list of the enzyme digestion in FIG. The value extracted by performing it until the last value is a candidate for the y series. Similarly, b series candidates are found by extracting the same mass number from the two lists. A value that does not meet the above conditions can be classified as an ion derived from a solvent or an internal fragment. FIG. 6 shows a list extracted as a b-sequence candidate and a list extracted as a b-sequence candidate. The difference corresponds to an amino acid by subtracting a close small value from a large value. From this result, the amino acid sequence analysis of SFL (I) DSGYR becomes possible.

上記において、縮合効果を有する酵素としては、リジルエンドペプチターゼ,トリプシン,キモトリプシン,サーモライシンの中から選ばれた少なくとも1種であっても同様の効果を得ることができる。   In the above, the same effect can be obtained even if the enzyme having a condensation effect is at least one selected from lysyl endopeptidase, trypsin, chymotrypsin, and thermolysin.

また、導入物質は、アミド,アニリン,ヒドラジン,フェニルヒドラジンの中から選ばれた少なくとも1種を有する物質であっても良い。   Further, the introduced substance may be a substance having at least one selected from amide, aniline, hydrazine, and phenylhydrazine.

また、有機溶媒はジメチルホルムアミド,酢酸エチル,アセトニトリルであっても良い。   The organic solvent may be dimethylformamide, ethyl acetate, or acetonitrile.

デノボシーケンス解析手順および縮合反応試薬キット。De novo sequence analysis procedure and condensation reaction reagent kit. 縮合反応の化学式。Chemical formula of the condensation reaction. ペプチドフラグメントのマススペクトル。Mass spectrum of peptide fragments. 質量分析計より得られた質量数リスト。Mass number list obtained from mass spectrometer. デノボシーケンス解析のフローチャート。Flow chart of de novo sequence analysis. 解析結果例。Analysis result example.

符号の説明Explanation of symbols

1…有機溶媒(ジメチルホルムアミド)、2…pH緩衝液(トリスバファー)、3…導入基用溶液(フェニルヒドラジン)、4…酵素(Lys−C)、5…反応用チューブ。   DESCRIPTION OF SYMBOLS 1 ... Organic solvent (dimethylformamide), 2 ... pH buffer solution (Tris buffer), 3 ... Solution for introduction groups (phenylhydrazine), 4 ... Enzyme (Lys-C), 5 ... Reaction tube.

Claims (7)

測定対象のタンパク質を酵素消化する際に、縮合効果を有する酵素を用い、有機溶媒存在下で、基質の10倍以上の導入物質を添加して、酵素消化を行うデノボ酵素消化ステップと、
該デノボ酵素消化を行った試料を衝突誘起解裂機能を備えた質量分析装置を用いてマススペクトルを取得するステップと、
該ステップで得られたマススペクトルと、通常の酵素消化を行った試料を衝突誘起解裂機能を備えた質量分析装置を用いて得られたマススペクトルと比較し、前記導入物質の質量数だけシフトしているマススペクトルを抽出し、抽出された値をy系列の候補とするステップと、
を含むことを特徴とするデノボシーケンス解析方法。
A de novo enzyme digestion step in which an enzyme having a condensation effect is used to enzymatically digest a protein to be measured, and in the presence of an organic solvent, an introduction substance more than 10 times the substrate is added to perform the enzyme digestion;
Obtaining a mass spectrum of the sample subjected to de novo enzyme digestion using a mass spectrometer having a collision-induced cleavage function;
The mass spectrum obtained in this step is compared with the mass spectrum obtained by using a mass spectrometer equipped with a collision-induced cleaving function for a sample subjected to normal enzyme digestion, and shifted by the mass number of the introduced substance. Extracting a mass spectrum that is being performed, and setting the extracted value as a candidate for a y-series;
A de novo sequence analysis method comprising:
請求項1において、
前記縮合効果を有する酵素が、リジルエンドペプチターゼ,トリプシン,キモトリプシン,サーモライシンの中から選ばれた少なくとも1種であることを特徴とするデノボシーケンス解析方法。
In claim 1,
The de novo sequence analysis method, wherein the enzyme having the condensation effect is at least one selected from lysyl endopeptidase, trypsin, chymotrypsin, and thermolysin.
請求項1または2において、
前記導入物質が、アミド,アニリン,ヒドラジン,フェニルヒドラジンの中から選ばれた少なくとも1種を有する物質であることを特徴とするデノボシーケンス解析方法。
In claim 1 or 2,
The de novo sequence analysis method, wherein the introduced substance is a substance having at least one selected from amide, aniline, hydrazine, and phenylhydrazine.
請求項1〜3のいずれかにおいて、
前記有機溶媒がジメチルホルムアミド,酢酸エチル,アセトニトリルのいずれかであることを特徴とするデノボシーケンス解析方法。
In any one of Claims 1-3,
The de novo sequence analysis method, wherein the organic solvent is dimethylformamide, ethyl acetate, or acetonitrile.
請求項1〜4のいずれかに記載のデノボシーケンス解析方法を実行するための、少なくとも前記導入物質を含むことを特徴とするデノボシーケンス用試薬キット。   A reagent kit for de novo sequencing, comprising at least the introduction substance for performing the de novo sequence analysis method according to any one of claims 1 to 4. 請求項1〜4のいずれかに記載のデノボシーケンス解析方法を実行するためのプログラムを含むことを特徴とするデノボシーケンス解析ソフト。   A de novo sequence analysis software comprising a program for executing the de novo sequence analysis method according to claim 1. 請求項6記載のデノボシーケンス解析ソフトを記憶した記憶媒体。


A storage medium storing the de novo sequence analysis software according to claim 6.


JP2006154148A 2006-06-02 2006-06-02 De novo sequence analysis method, analysis software, storage medium storing analysis software, reagent kit Expired - Fee Related JP4832168B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006154148A JP4832168B2 (en) 2006-06-02 2006-06-02 De novo sequence analysis method, analysis software, storage medium storing analysis software, reagent kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006154148A JP4832168B2 (en) 2006-06-02 2006-06-02 De novo sequence analysis method, analysis software, storage medium storing analysis software, reagent kit

Publications (2)

Publication Number Publication Date
JP2007322293A true JP2007322293A (en) 2007-12-13
JP4832168B2 JP4832168B2 (en) 2011-12-07

Family

ID=38855246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006154148A Expired - Fee Related JP4832168B2 (en) 2006-06-02 2006-06-02 De novo sequence analysis method, analysis software, storage medium storing analysis software, reagent kit

Country Status (1)

Country Link
JP (1) JP4832168B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014052331A (en) * 2012-09-10 2014-03-20 Shimadzu Corp Analysis method and apparatus for amino acid sequence
JP2021534408A (en) * 2018-08-17 2021-12-09 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Methods for DE NOVO Protein Sequencing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004219418A (en) * 2003-01-13 2004-08-05 Agilent Technol Inc Method of selecting n-terminal peptide and c-terminal peptide in proteomics
JP2004294431A (en) * 2003-03-11 2004-10-21 Shimadzu Corp Method of determining amino acid sequence of peptide
JP2005139174A (en) * 2003-10-16 2005-06-02 Shimadzu Corp Method for converting protein or peptide to its sulfonic acid derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004219418A (en) * 2003-01-13 2004-08-05 Agilent Technol Inc Method of selecting n-terminal peptide and c-terminal peptide in proteomics
JP2004294431A (en) * 2003-03-11 2004-10-21 Shimadzu Corp Method of determining amino acid sequence of peptide
JP2005139174A (en) * 2003-10-16 2005-06-02 Shimadzu Corp Method for converting protein or peptide to its sulfonic acid derivative

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014052331A (en) * 2012-09-10 2014-03-20 Shimadzu Corp Analysis method and apparatus for amino acid sequence
JP2021534408A (en) * 2018-08-17 2021-12-09 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Methods for DE NOVO Protein Sequencing
US12000840B2 (en) 2018-08-17 2024-06-04 Regeneron Pharmaceuticals, Inc. Methods for de novo protein sequencing

Also Published As

Publication number Publication date
JP4832168B2 (en) 2011-12-07

Similar Documents

Publication Publication Date Title
Parker et al. Forensic proteomics
Na et al. Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini
US6379970B1 (en) Analysis of differential protein expression
Lothrop et al. Deciphering post-translational modification codes
Lubec et al. Searching for hypothetical proteins: theory and practice based upon original data and literature
Knight et al. Phosphospecific proteolysis for mapping sites of protein phosphorylation
Beaudette et al. Proteomic techniques to probe the ubiquitin landscape
WO2010065322A1 (en) Concurrent identification of multitudes of polypeptides
US20050048564A1 (en) Protein expression profile database
Li et al. Improved sequence variant analysis strategy by automated false positive removal
KR100805775B1 (en) An additive scoring method for modified polypeptide
Brown et al. Direct seminal fluid identification by protease‐free high‐resolution mass spectrometry
Jouber et al. Identification by mass spectrometry of two‐dimensional gel electrophoresis‐separated proteins extracted from lager brewing yeast
Schrader et al. The process chain for peptidomic biomarker discovery
JP4832168B2 (en) De novo sequence analysis method, analysis software, storage medium storing analysis software, reagent kit
WO2008011379A4 (en) Oxidized apoa1 determination by mass spectrometry
US20140156206A1 (en) Detection and Quantification of Polypeptides Using Mass Spectrometry
Boudier-Lemosquet et al. Introducing protein deamidation: Landmark discoveries, societal outreach, and tentative priming workflow to address deamidation
James Chips for proteomics: a new tool or just hype?
Löhr et al. Proteomics in pancreatic disease
US20200363423A1 (en) Mistranslation method for assessing the effects of amino acid substitutions on protein stability and function
JP4614960B2 (en) Testing the amino acid sequence of peptides by isotopic ratio
WO2017162888A1 (en) Universal mrm tags for protein quantification
Wu et al. Analysis of protein phosphorylation using mass spectrometry
Kuppusamy et al. “Omics” approaches to determine protease degradomes in complex biological matrices

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090520

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090520

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110609

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110803

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110823

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110920

R150 Certificate of patent or registration of utility model

Ref document number: 4832168

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140930

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees